Endurant Capital Management LP Atri Cure, Inc. Transaction History

Endurant Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $1.39 Million - $1.73 Million	-24,253 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $1.54 Million - $2.11 Million	24,253 New	24,253 $1.69 Million
Q2 2020 Aug 14, 2020	SELL	$31.78 - $51.19 $1.06 Million - $1.71 Million	-33,453 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $819,263 - $1.47 Million	33,453 New	33,453 $1.12 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $827,447 - $1.12 Million	-34,391 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $4.4 Million - $6 Million	-184,647 Reduced 84.3%	34,391 $858,000
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $1.28 Million - $1.46 Million	-47,539 Reduced 17.83%	219,038 $6.54 Million
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $7.03 Million - $8.89 Million	266,577 New	266,577 $7.14 Million

210

49.3M

111K

23.8K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.3B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.